These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32380408)

  • 21. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
    Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
    J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.
    Vyrla D; Nikolaidis G; Oakley F; Perugorria MJ; Tsichlis PN; Mann DA; Eliopoulos AG
    J Immunol; 2016 May; 196(10):4298-310. PubMed ID: 27053764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs.
    Gao M; Li X; He L; Yang J; Ye X; Xiao F; Wei H
    Drug Des Devel Ther; 2019; 13():3579-3589. PubMed ID: 31802846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mitochondria-targeting antioxidant MitoQ alleviated lipopolysaccharide/ d-galactosamine-induced acute liver injury in mice.
    Hu K; Xiao L; Li L; Shen Y; Yang Y; Huang J; Wang Y; Zhang L; Wen S; Tang L
    Immunol Lett; 2021 Dec; 240():24-30. PubMed ID: 34525396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?
    Lu C; Zhang D; Whiteman M; Armstrong JS
    Antioxid Redox Signal; 2008 Mar; 10(3):651-60. PubMed ID: 17999633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
    Swain MG
    Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.
    Mukhopadhyay P; Horváth B; Zsengellėr Z; Bátkai S; Cao Z; Kechrid M; Holovac E; Erdėlyi K; Tanchian G; Liaudet L; Stillman IE; Joseph J; Kalyanaraman B; Pacher P
    Free Radic Biol Med; 2012 Sep; 53(5):1123-38. PubMed ID: 22683818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular adenosine controls NKT-cell-dependent hepatitis induction.
    Subramanian M; Kini R; Madasu M; Ohta A; Nowak M; Exley M; Sitkovsky M; Ohta A
    Eur J Immunol; 2014 Apr; 44(4):1119-29. PubMed ID: 24448964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
    Lowes DA; Thottakam BM; Webster NR; Murphy MP; Galley HF
    Free Radic Biol Med; 2008 Dec; 45(11):1559-65. PubMed ID: 18845241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
    Chen XJ; Wang L; Song XY
    Biomed Pharmacother; 2020 May; 125():110003. PubMed ID: 32187955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MitoQ--a mitochondria-targeted antioxidant.
    Tauskela JS
    IDrugs; 2007 Jun; 10(6):399-412. PubMed ID: 17642004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ.
    Dare AJ; Bolton EA; Pettigrew GJ; Bradley JA; Saeb-Parsy K; Murphy MP
    Redox Biol; 2015 Aug; 5():163-168. PubMed ID: 25965144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ.
    Stucki DM; Ruegsegger C; Steiner S; Radecke J; Murphy MP; Zuber B; Saxena S
    Free Radic Biol Med; 2016 Aug; 97():427-440. PubMed ID: 27394174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.
    Goto M; Tanaka Y; Murakawa M; Kadoshima-Yamaoka K; Inoue H; Murafuji H; Nagahira A; Kanki S; Hayashi Y; Nagahira K; Ogata A; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Int Immunopharmacol; 2009 Oct; 9(11):1347-51. PubMed ID: 19671449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease.
    Hao L; Sun Q; Zhong W; Zhang W; Sun X; Zhou Z
    Redox Biol; 2018 Apr; 14():626-636. PubMed ID: 29156373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity.
    Ojano-Dirain CP; Antonelli PJ; Le Prell CG
    Otol Neurotol; 2014 Mar; 35(3):533-9. PubMed ID: 24518411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance.
    Kang L; Liu S; Li J; Tian Y; Xue Y; Liu X
    Cell Prolif; 2020 Mar; 53(3):e12779. PubMed ID: 32020711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.